These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6214868)

  • 21. [Clinical applications of beta-thromboglobulin and platelet factor 4 radioimmune assays (author's transl)].
    Lokiec F; Najean Y
    Nouv Presse Med; 1980 Oct; 9(38):2833-4, 2837-8. PubMed ID: 6160454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistological comparison of platelet factor 4 (PF4), fibronectin (Fn) and factor VIII related antigen (VIIIR:Ag) in human platelet granules.
    Giddings JC; Brookes LR; Piovella F; Bloom AL
    Br J Haematol; 1982 Sep; 52(1):79-88. PubMed ID: 6810914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
    Rosove MH; Hocking WG; Harwig SS; Perloff JK
    Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the beta-TG/PF4 ratio have any value?
    Arocha-Piñango CL; Ojeda A
    Thromb Haemost; 1983 Apr; 49(2):147. PubMed ID: 6191402
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelet activation in response to phlebotomy. An experimental study of healthy blood donors.
    Eriksson KA; Sigvaldason A; Lindholm A; Safai-Kutti S; Kutti J
    Acta Med Scand; 1982; 212(3):121-3. PubMed ID: 6183925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet factor release following heparin administration and during extracorporeal circulation.
    Flicker W; Milthorpe BK; Schindhelm K; Odell RA; McPherson J; Farrell PC
    Trans Am Soc Artif Intern Organs; 1982; 28():431-6. PubMed ID: 6219490
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunological localisation of beta-thromboglobulin and platelet factor 4 in human megakaryocytes and platelets.
    McLaren KM; Pepper DS
    J Clin Pathol; 1982 Nov; 35(11):1227-31. PubMed ID: 6183294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-released proteins as molecular markers for the activation process.
    Walz DA
    Semin Thromb Hemost; 1984 Oct; 10(4):270-9. PubMed ID: 6240116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of anticoagulant mixtures on BTG and PF4 levels.
    Randi ML; Fabris F; Casonato A; Girolami A
    Thromb Haemost; 1981 Aug; 46(2):569. PubMed ID: 6171043
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunoelectron microscopic localization of platelet factor 4 and fibrinogen in the granules of human platelets.
    Pham TD; Kaplan KL; Butler VP
    J Histochem Cytochem; 1983 Jul; 31(7):905-10. PubMed ID: 6343481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentrations of plbatelet-specific proteins in coronary artery disease.
    Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaindl F
    Cardiology; 1981; 68(3):129-38. PubMed ID: 6172197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
    Visentin GP; Ford SE; Scott JP; Aster RH
    J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo release and turnover of secreted platelet antiheparin proteins in rhesus monkey (Macaca mulatta).
    Musial J; Niewiarowski S; Edmunds LH; Addonizio VP; Nicolaou KC; Colman RW
    Blood; 1980 Oct; 56(4):596-607. PubMed ID: 6158350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance of platelet factor four (PF4) plasma levels in multiple sclerosis.
    Cananzi AR; Ferro-Milone F; Grigoletto F; Toldo M; Meneghini F; Bortolon F; D'Andrea G
    Acta Neurol Scand; 1987 Aug; 76(2):79-85. PubMed ID: 2960124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Objective assessment of heparin requirements for hemodialysis in humans.
    Ireland H; Lane DA; Curtis JR
    J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis.
    O'Brien JR; Etherington MD; Pashley M
    Thromb Haemost; 1984 Jul; 51(3):354-7. PubMed ID: 6495255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
    Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
    Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced platelet release reaction in insulin-dependent and insulin-independent diabetic patients.
    Davì G; Rini GB; Averna M; Novo S; Di Fede G; Mattina A; Notarbartolo A; Strano A
    Haemostasis; 1982; 12(3):275-81. PubMed ID: 6183173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardization of beta-thromboglobulin and platelet factor 4: a collaborative study to investigate the sources and extent of variation in the measurement of platelet specific proteins.
    Curtis AD; Kerry PJ
    Thromb Haemost; 1983 Oct; 50(3):686-9. PubMed ID: 6196853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Release of Tissue Factor Pathway Inhibitor and Platelet Factor 4 After Heparin Injection in Patients with Thrombocytosis.
    Cella G; Conard J; Manai S; Luzzatto G; Paolini R; Toffoli S; Boeri G; Vianello A; Girolami A; Samama MM; Strauss WE
    Hematology; 1997; 2(3):235-41. PubMed ID: 27406868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.